Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSTEL IV: nifedipine versus placebo for early PPROM
NL-OMON35899Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Preterm prelabor rupture of membranes (PPROM) comparing Nifedipine with Placebo (2 arms). Primary endpoint: Composite neonatal morbidity. Started Oct 2012; status: active, not recruiting.
02
Drugs
nifedipine
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on NL-OMON35899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35899.